Study highlights how telehealth can facilitate treatment for people with opioid use disorder

NewsGuard 100/100 Score

The majority of individuals with opioid use disorder (OUD) face access barriers to evidence-based treatment. While the COVID-19 pandemic offered an opportunity to address OUD treatment access barriers by allowing for expanded use of telehealth, is it not yet clear if this technology will help eliminate those barriers or exacerbate pre-existing treatment inequities.

A study of staff working with marginalized patients at low-barrier treatment programs in Philadelphia has highlighted how telehealth can facilitate treatment for many with OUD; prescribers and staff in the study indicated that telehealth has lowered access barriers to treatment. However, they also shared that the digital divide still limits the effectiveness of this technology and their concerns that telehealth visits many not be as in-person treatment for some patients who struggle to engage in treatment.

Telehealth may address many access issues. However, barriers to implementation remain, including patient ability and desire to attend healthcare appointments virtually. In addition, the potential for telehealth models to extend OUD care to patients currently underserved by in-person models may partially depend on clinician comfort treating patients deemed unstable via this modality."

Shoshana V. Aronowitz, PhD, MSHP, FNP-BC, Lead-Investigator, Assistant Professor in Penn Nursing's Department of Family and Community Health

Results of the study have been published in an article, "Telehealth for Opioid Use Disorder Treatment in Low‑Barrier Clinic Settings: An Exploration of Clinician and Staff Perspectives" in Harm Reduction Journal.

Source:
Journal reference:

Aronowitz, S.V., et al. (2021) Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives. Harm Reduction Journal. doi.org/10.1186/s12954-021-00572-7.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lessons learned: Strategies for future pandemic response based on mpox experience